Access to world-class prostate treatment is widely distributed across several leading nations renowned for advanced medical infrastructure, including the United States, Germany, South Korea, Japan, and Israel. These countries feature top-tier urological research institutions, pioneering surgical robotics training centers, and early adoption pathways for cutting-edge focal therapies like TULSA-PRO and proton beam radiation.